Reports

Ideas That Generate Results

Global Pharmaceutical Market Forecast to 2012

Global Pharmaceutical Market Forecast to 2012

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Feb, 2011| No. of Pages : 190

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1600.00
CD-ROM Mail Delivery
US$ 1800.00
Hard Copy Mail Delivery
US$ 1800.00
Electronic Access - Multi-User License
US$ 2400.00

List of Figures:

Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2008-2010
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2008-2010
Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 2-4: Global - Pharmaceutical Market by Region (%), 2009
Figure 2-5: Global – Revenue of Leading Pharmaceutical Companies (Billion US$), 2009
Figure 3-1: North America - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-2: North America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-3: US - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-4: US - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-5: Canada - Pharmaceutical Market (Billion CAD), 2008-2010
Figure 3-6: Canada - Forecast for Pharmaceutical Market (Billion CAD), 2011-2013
Figure 3-7: Latin America - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-8: Latin America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-9: Brazil - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-10: Brazil - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-11: Mexico - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-12: Mexico - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-13: Argentina - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-14: Argentina - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-15: Chile - Pharmaceutical Market (Million US$), 2008-2010
Figure 3-16: Chile - Forecast for Pharmaceutical Market (Million US$), 2011-2013
Figure 3-17: Europe - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-18: Europe - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-19: Germany - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-20: Germany - Share of Export in Pharmaceutical Market (2009)
Figure 3-21: Germany - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-22: France - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-23: France - Share of Generics and Branded Drugs in Pharmaceutical Market (2009)
Figure 3-24: France - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-25: Italy - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-26: Italy - Share of Prescription and Non-Prescription Drugs in Pharmaceutical Market (2009)
Figure 3-27: Italy - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-28: Spain - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-29: Spain - Share of Prescription and OTC Drugs in Pharmaceutical Market (2010)
Figure 3-30: Spain - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-31: UK - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-32: UK - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-33: Russia - Pharmaceutical Market (Billion Rubles), 2008-2010
Figure 3-34: Russia - Share of Commercial and State Sector in Pharmaceutical Market (2009)
Figure 3-35: Russia - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market
Figure 3-36: Russia - Forecast for Pharmaceutical Market (Billion Rubles), 2011-2013
Figure 3-37: Turkey - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-38: Turkey - Share of Branded and Generic Drugs in Pharmaceutical Market (2009)
Figure 3-39: Turkey - Share of Therapy Areas in Pharmaceutical Market (2009)
Figure 3-40: Turkey - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market (2009)
Figure 3-41: Turkey - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-42: Poland - Pharmaceutical Market (Billion PLN), 2008-2010
Figure 3-43: Poland - Forecast for Pharmaceutical Market (Billion PLN), 2011-2013
Figure 3-44: Hungary - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-45: Hungary - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-46: Ukraine - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-47: Ukraine - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-48: Czech Republic - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-49: Czech Republic - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-50: Romania - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-51: Romania - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-52: Asia-Pacific - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-53: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-54: India - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-55: India - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-56: China - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-57: China - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-58: Japan - Pharmaceutical Market (Trillion JPY), 2008-2010
Figure 3-59: Japan - Forecast for Pharmaceutical Market (Trillion JPY), 2011-2013
Figure 3-60: South Korea - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-61: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-62: Indonesia - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-63: Indonesia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-64: Vietnam - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-65: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-66: Thailand - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-67: Thailand - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-68: Philippines - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-69: Philippines - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-70: Malaysia - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-71: Malaysia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-72: Australia - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-73: Australia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-74: New Zealand - Pharmaceutical Market (Million US$), 2009 & 2010
Figure 3-75: New Zealand - Forecast for Pharmaceutical Market (Million US$), 2011-2013
Figure 3-76: Saudi Arabia - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-77: Saudi Arabia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-78: UAE - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-79: UAE - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-80: South Africa - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-81: South Africa - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-82: Egypt - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-83: Egypt - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-84: Nigeria - Pharmaceutical Market (Million US$), 2009 & 2010
Figure 3-85: Nigeria - Forecast for Pharmaceutical Market (Million US$), 2011-2013

List of Tables:

Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2009
Table 2-2: Global - Leading Therapy Classes by Sales (Billion US$), 2009
Table 2-3: Global - Leading Drugs by Sales (Billion US$), 2009
Table 3-1: US - Healthcare Statistics (2008-2010)
Table 3-2: US - Forecast for Healthcare Statistics (2011-2013)
Table 3-3: Canada - Healthcare Statistics (2008-2010)
Table 3-4: Canada - Forecast for Healthcare Statistics (2011-2013)
Table 3-5: Brazil - Healthcare Statistics (2008-2010)
Table 3-6: Brazil - Forecast for Healthcare Statistics (2011-2013)
Table 3-7: Mexico - Healthcare Statistics (2008-2010)
Table 3-8: Mexico - Forecast for Healthcare Statistics (2011-2013)
Table 3-9: Argentina - Healthcare Statistics (2008-2010)
Table 3-10: Argentina - Forecast for Healthcare Statistics (2011-2013)
Table 3-11: Chile - Healthcare Statistics (2008-2010)
Table 3-12: Chile - Forecast for Healthcare Statistics (2011-2013)
Table 3-13: Germany - Healthcare Statistics (2008-2010)
Table 3-14: Germany - Forecast for Healthcare Statistics (2011-2013)
Table 3-15: France - Healthcare Statistics (2008-2010)
Table 3-16: France - Forecast for Healthcare Statistics (2011-2013)
Table 3-17: Italy - Healthcare Statistics (2008-2010)
Table 3-18: Italy - Forecast for Healthcare Statistics (2011-2013)
Table 3-19: Spain - Healthcare Statistics (2008-2010)
Table 3-20: Spain - Forecast for Healthcare Statistics (2011-2013)
Table 3-21: UK - Healthcare Statistics (2008-2010)
Table 3-22: UK - Forecast for Healthcare Statistics (2011-2013)
Table 3-23: Russia - Healthcare Statistics (2008-2010)
Table 3-24: Russia - Forecast for Healthcare Statistics (2011-2013)
Table 3-25: Turkey - Healthcare Statistics (2008-2010)
Table 3-26: Turkey - Forecast for Healthcare Statistics (2011-2013)
Table 3-27: Poland - Healthcare Statistics (2008-2010)
Table 3-28: Poland - Forecast for Healthcare Statistics (2011-2013)
Table 3-29: Hungary - Healthcare Statistics (2008-2010)
Table 3-30: Hungary - Forecast for Healthcare Statistics (2011-2013)
Table 3-31: Ukraine - Healthcare Statistics (2008-2010)
Table 3-32: Ukraine - Forecast for Healthcare Statistics (2011-2013)
Table 3-33: Czech Republic - Healthcare Statistics (2008-2010)
Table 3-34: Czech Republic - Forecast for Healthcare Statistics (2011-2013)
Table 3-35: Romania - Healthcare Statistics (2008-2010)
Table 3-36: Romania - Forecast for Healthcare Statistics (2011-2013)
Table 3-37: India - Healthcare Statistics (2008-2010)
Table 3-38: India - Forecast for Healthcare Statistics (2011-2013)
Table 3-39: China - Healthcare Statistics (2008-2010)
Table 3-40: China - Forecast for Healthcare Statistics (2011-2013)
Table 3-41: Japan - Healthcare Statistics (2008-2010)
Table 3-42: Japan - Forecast for Healthcare Statistics (2011-2013)
Table 3-43: South Korea - Healthcare Statistics (2008-2010)
Table 3-44: South Korea - Forecast for Healthcare Statistics (2011-2013)
Table 3-45: Indonesia - Healthcare Statistics (2008-2010)
Table 3-46: Indonesia - Forecast for Healthcare Statistics (2011-2013)
Table 3-47: Vietnam - Healthcare Statistics (2008-2010)
Table 3-48: Vietnam - Forecast for Healthcare Statistics (2011-2013)
Table 3-49: Thailand - Healthcare Statistics (2008-2010)
Table 3-50: Thailand - Forecast for Healthcare Statistics (2011-2013)
Table 3-51: Philippines - Healthcare Statistics (2008-2010)
Table 3-52: Philippines - Forecast for Healthcare Statistics (2011-2013)
Table 3-53: Malaysia - Healthcare Statistics (2008-2010)
Table 3-54: Malaysia - Forecast for Healthcare Statistics (2011-2013)
Table 3-55: Australia - Healthcare Statistics (2008-2010)
Table 3-56: Australia - Forecast for Healthcare Statistics (2011-2013)
Table 3-57: New Zealand - Healthcare Statistics (2008-2010)
Table 3-58: New Zealand - Forecast for Healthcare Statistics (2011-2013)
Table 3-59: Saudi Arabia - Healthcare Statistics (2008-2010)
Table 3-60: Saudi Arabia - Forecast for Healthcare Statistics (2011-2013)
Table 3-61: South Africa - Healthcare Statistics (2008-2010)
Table 3-62: South Africa - Forecast for Healthcare Statistics (2011-2013)
Table 3-63: Egypt - Healthcare Statistics (2008-2010)
Table 3-64: Egypt - Forecast for Healthcare Statistics (2011-2013)
Table 3-65: Nigeria - Healthcare Statistics (2008-2010)
Table 3-66: Nigeria - Forecast for Healthcare Statistics (2011-2013)
Table 4-1: Pfizer Inc - Strengths & Weaknesses
Table 4-2: Sanofi-Aventis - Strengths & Weaknesses
Table 4-3: GlaxoSmithKline plc - Strengths & Weaknesses
Table 4-4: Novartis International AG - Strengths & Weaknesses
Table 4-5: AstraZeneca Plc - Strengths & Weaknesses

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.